Boston, MA -- (SBWIRE) -- 02/13/2014 -- VueKlar Cardiovascular Ltd. (VueKlar) is a medical device company. The company develops cardiovascular implants and interventional devices. Its implants include stents, heart valves, septal occluders, vena cava filters, vessel filters for distal protection, left atrial apendage closure devices, vascular closure devices, biliary and urological stents, gastrointestinal and bronchial stents, stents for transjugular intrahepatic porto-systemic shunt, and guide wires, catheters, balloons, delivery systems, cannulae, biopsy needles. VueKlar's MR-enhancement is suitable for cardiovascular implants, and incorporates biocompatible, electromagnetic, resonant circuits tuned to the imaging system into an implanted device. The company markets products throughout the country. VueKlar Cardiovascular is headquartered in Edinburgh, the UK.

View Full Report Details and Table of Contents

This report is a source for data, analysis and actionable intelligence on the VueKlar Cardiovascular Ltd. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Get This Report

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Medical Devices research reports at Fast Market Research

You may also be interested in these related reports:

- Cytori Therapeutics, Inc. (CYTX) - Product Pipeline Analysis, 2013 Update
- MediPoint: Peripheral Vascular Stents for the Lower Extremity - APAC Analysis and Market Forecasts
- MediPoint: Peripheral Vascular Stents - Global Analysis and Market Forecasts
- MediPoint: Peripheral Vascular Stents for the Lower Extremity - South America Analysis and Market Forecasts
- Maquet Cardiovascular, LLC - Product Pipeline Analysis, 2013 Update
- CorMatrix Cardiovascular, Inc. - Product Pipeline Analysis, 2013 Update
- MediPoint: Peripheral Vascular Stents for the Lower Extremity - US Analysis and Market Forecasts
- MediPoint: Peripheral Vascular Stents for the Lower Extremity - EU Analysis and Market Forecasts
- MediPoint: Peripheral Vascular Stents for the Lower Extremity - Current and Future Players
- bioMerieux S.A. (BIM) - Product Pipeline Analysis, 2013 Update